Pay in 4 interest-free payments of $7.43 Learn more
Ships within 48 hours · Estimated delivery Aug 23 - Aug 28
Results vary based on age, labs, health history, dosage, and consistency
Available at: (Accessed March 15, 2018)
These results indirectly indicate that the oxidative damage in rats increased
Safety Information Do not exceed the recommended dosage
The same analysis flagged a higher adverse-event relative risk for retatrutide (RR 4.10 vs 2.78), consistent with a higher gastrointestinal burden at the top doses
Annualized cost comparisons in 2026: Bariatric surgery (gastric sleeve or bypass): ,000 to ,000 one-time, often covered by insurance for severe obesity Wegovy at list price: about ,200 per year Zepbound at list price: about ,720 per year Compounded semaglutide (legitimate US pharmacy): ,800 to ,000 per year Compounded tirzepatide: ,000 to ,000 per year Retatrutide at launch will likely fit in the Wegovy/Zepbound range at list price, with significantly lower out-of-pocket cost for insured patients with savings card eligibility
